TSC article with ridiculously inaccurate dox comparator arm for analysis is out there somewhere.
TSC article with ridiculously inaccurate dox comparator arm for analysis is out there somewhere - basis for their article is inaccurate imo
I hear there is a TSC article out there somewhere quoting dox alone response rates in other trials as 20% - this is simply inaccurate. If you look at the dox alone numbers in BLINDED TRIALS with independent Data Monitoring Committees - from 9% to 13%...there quoting 20% is like amateur hour. Will post a comment once I see it....shorts clearly getting nervous....how will they cover 12 million short shares when good data and a partnership comes..